Literature DB >> 8733126

Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism.

J Baron1, K K Winer, J A Yanovski, A W Cunningham, L Laue, D Zimmerman, G B Cutler.   

Abstract

Parathyroid hormone secretion is negatively regulated by a 7-transmembrane domain, G-protein coupled Ca(2+)-sensing receptor. We hypothesized that activating mutations in this receptor might cause autosomal dominant hypoparathyroidism (ADHP). Consistent with this hypothesis, we identified, in two families with ADHP, heterozygous missense mutations in the Ca(2+)-sensing receptor gene that cosegregated with the disorder. None of 50 normal controls had either mutation. We also identified a de novo, missense Ca(2+)-sensing receptor mutation in a child with severe sporadic hypoparathyroidism. The amino acid substitution in one ADHP family affected the N-terminal, extracellular domain of the receptor. The other mutations involved the transmembrane region. Unlike patients with acquired hypoparathyroidism, patients with these mutations had hypercalciuria even at low serum calcium concentrations. Their greater hypercalciuria presumably reflected activation of Ca(2+)-sensing receptors in kidney cells, where the receptor negatively regulates calcium reabsorption. This augmented hypercalciuria increases the risk of renal complications and thus has implications for the choice of therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8733126     DOI: 10.1093/hmg/5.5.601

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  30 in total

Review 1.  Familial hypocalciuric hypercalcemia.

Authors:  D A Heath
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  The Venus flytrap of periplasmic binding proteins: an ancient protein module present in multiple drug receptors.

Authors:  C B Felder; R C Graul; A Y Lee; H P Merkle; W Sadee
Journal:  AAPS PharmSci       Date:  1999

3.  Hypoparathyroidism and central diabetes insipidus: in search of the link.

Authors:  Ori Eyal; Asaf Oren; Harald Jüppner; Raz Somech; Annamaria De Bellis; Michael Mannstadt; Auryan Szalat; Margalit Bleiberg; Yosef Weisman; Naomi Weintrob
Journal:  Eur J Pediatr       Date:  2014-11-04       Impact factor: 3.183

Review 4.  The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia.

Authors:  L M Calvi; E Schipani
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

5.  Recessive versus imprinted disorder: consanguinity can impede establishing the diagnosis of autosomal dominant pseudohypoparathyroidism type Ib.

Authors:  Serap Turan; Leyla Akin; Teoman Akcay; Erdal Adal; Sevil Sarikaya; Murat Bastepe; Harald Jüppner
Journal:  Eur J Endocrinol       Date:  2010-06-10       Impact factor: 6.664

Review 6.  Primary hyperparathyroidism: pathophysiology and impact on bone.

Authors:  A Khan; J Bilezikian
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

Review 7.  Genetic Disorders of Parathyroid Development and Function.

Authors:  Rebecca J Gordon; Michael A Levine
Journal:  Endocrinol Metab Clin North Am       Date:  2018-10-12       Impact factor: 4.741

8.  Calcimimetics--fooling the calcium receptor.

Authors:  Eberhard Ritz
Journal:  Pediatr Nephrol       Date:  2004-10-27       Impact factor: 3.714

Review 9.  Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations.

Authors:  Ogo I Egbuna; Edward M Brown
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

Review 10.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.